[go: up one dir, main page]

AU2003255823A1 - Diagnostic test - Google Patents

Diagnostic test

Info

Publication number
AU2003255823A1
AU2003255823A1 AU2003255823A AU2003255823A AU2003255823A1 AU 2003255823 A1 AU2003255823 A1 AU 2003255823A1 AU 2003255823 A AU2003255823 A AU 2003255823A AU 2003255823 A AU2003255823 A AU 2003255823A AU 2003255823 A1 AU2003255823 A1 AU 2003255823A1
Authority
AU
Australia
Prior art keywords
diagnostic test
diagnostic
test
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003255823A
Inventor
Du Ming-Qing
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University College London
Original Assignee
University College London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0219890A external-priority patent/GB0219890D0/en
Application filed by University College London filed Critical University College London
Publication of AU2003255823A1 publication Critical patent/AU2003255823A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2003255823A 2002-08-24 2003-08-20 Diagnostic test Abandoned AU2003255823A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0219890.1 2002-08-24
US40571702P 2002-08-26 2002-08-26
US60/405,717 2002-08-26
GB0219890A GB0219890D0 (en) 2002-08-27 2002-08-27 Diagnostic test
PCT/GB2003/003637 WO2004018711A2 (en) 2002-08-24 2003-08-20 Diagnostic test

Publications (1)

Publication Number Publication Date
AU2003255823A1 true AU2003255823A1 (en) 2004-03-11

Family

ID=31979987

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003255823A Abandoned AU2003255823A1 (en) 2002-08-24 2003-08-20 Diagnostic test

Country Status (2)

Country Link
AU (1) AU2003255823A1 (en)
WO (1) WO2004018711A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110229895A (en) * 2019-06-04 2019-09-13 广州鼓润医疗科技有限公司 A kind of molecular marked compound of uterine neck intraepithelial neoplasia that predicting human papilloma virus positive patient

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2937696B1 (en) 2012-12-20 2018-06-06 National University Corporation Hokkaido University Method for detecting prostatic basal cells
WO2016046635A1 (en) * 2014-09-25 2016-03-31 Institut Pasteur Methods for characterizing human papillomavirus associated cervical lesions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10109259A1 (en) * 2000-02-25 2001-09-13 Giesing Michael Characterizing increased dedifferentiation of cancer cells useful for diagnosing cancer, particularly early cervical cancer, comprises applying body fluids to a foil covered slide and detecting dye-marked cells by laser

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110229895A (en) * 2019-06-04 2019-09-13 广州鼓润医疗科技有限公司 A kind of molecular marked compound of uterine neck intraepithelial neoplasia that predicting human papilloma virus positive patient

Also Published As

Publication number Publication date
WO2004018711A3 (en) 2004-07-22
WO2004018711A2 (en) 2004-03-04

Similar Documents

Publication Publication Date Title
AU2003282642A1 (en) Blood testing apparatus
AU2003223735A1 (en) Diagnostic test for elemental imbalances
AU2003272430A1 (en) Diffraction-based diagnostic devices
AUPQ886100A0 (en) Diagnostic test
GB0104690D0 (en) Diagnostic test
AU2003221968A1 (en) Diffracation-based diagnostic devices
AU2003237344A1 (en) Testing device
AU2003268457A1 (en) Biomap analysis
AU2003230942A1 (en) Diffraction-based diagnostic devices
AU2003224405A1 (en) Fluid tester
AU2003284512A1 (en) Analysis instrument
AU2003227908A1 (en) Test apparatus
AU2003278040A1 (en) Diagnostic device
AU2002327860A1 (en) Diagnostic methods
AU2003217595A1 (en) Integrated vi probe
AU2003202012A1 (en) Toxicity test
AU2003228555A1 (en) Diffraction-based diagnostic devices
AU2003255823A1 (en) Diagnostic test
AU2003275980A1 (en) Supporting element for conducting diagnostic tests
GB0200757D0 (en) Diagnostic methods
AU2002951543A0 (en) Condition analysis
AU2002950212A0 (en) Diagnostic testing process
GB0224559D0 (en) Test
GB0219890D0 (en) Diagnostic test
AU2002100720A4 (en) Future diagnostic set

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase